Affordable Access

Publisher Website

A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)—Case report and review of the literature

Authors
Journal
Leukemia Research
0145-2126
Publisher
Elsevier
Publication Date
Volume
19
Issue
6
Identifiers
DOI: 10.1016/0145-2126(94)00150-9
Keywords
  • Acute Myeloblastic Leukemia
  • M4
  • M5 Subtypes
  • Karyotype
  • T(8P11:V) Morphocytochemistry
  • Ultrastructure
  • Phenotype
Disciplines
  • Biology
  • Chemistry
  • Medicine

Abstract

Abstract Acute myeloblastic leukemia (AML) with t(8:16) or its variant t(8:V) has been rarely reported. A high proportion of patients are infants and children, often with a bleeding tendency and disseminated intravascular coagulopathy (DIC). Only one-third of the de novo patients remain in the first complete remission following multiagent chemotherapy and bone marrow transplantation (BMT). Morphocytochemically, the disorder is classified as an M5, M4, or M4/M5 variant. In the presented case, with the variant t(8:19)(p11:q13), comprehensive light and electron microscopic blast cell characterization showed monocytic and granulocytic features compatible with the M4 subtype (on the monocytic predominance range of the French-American-British classification scale). Although hemophagocytosis, one of the hallmarks of the disease, was rare in our patient, numerous autophagic vacuoles were present. Immuno- and genotyping showed a myelomonocytic phenotype with no evidence of early progenitor antigen expression or mixed leukemia. These results and those of previous reports support the high specificity of t(8:16) or its variants to the unique M4/M5 type leukemia and the role of a gene on 8p11 in this specific transformation.

There are no comments yet on this publication. Be the first to share your thoughts.